Literature DB >> 2514618

Assessment of canine intestinal permeability, using 51Cr-labeled ethylenediaminetetraacetate.

E J Hall1, R M Batt, A Brown.   

Abstract

The 51Cr-labeled EDTA was validated as a suitable permeability probe in dogs for measurement of passive, unmediated diffusion across intestinal mucosa via intercellular pathways. The 51Cr-labeled EDTA was stable in aqueous solution and did not bind to biologic tissue and fluids. After incubation of 51Cr-labeled EDTA in isolated jejunal loops, analytic subcellular fractionation of jejunal mucosa on reorientating sucrose-density gradients was performed, and no association of 51Cr-labeled EDTA with particulate intracellular organelles was detected. Intravenously administered 51Cr-labeled EDTA was rapidly and completely excreted in urine. Intestinal permeability to 51Cr-labeled EDTA after oral administration was assessed in healthy dogs. The percentage of the administered dose of 51Cr-labeled EDTA excreted in the urine in 24 hours ranged from 2.3 to 17.6% (median, 13%).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514618

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Development and validation of a method for simultaneous separation and quantification of 5 different sugars in canine urine.

Authors:  J M Steiner; D A Williams; E M Moeller
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Dietary modulation of gluten sensitivity in a naturally occurring enteropathy of Irish setter dogs.

Authors:  E J Hall; R M Batt
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

3.  Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs.

Authors:  E J Hall; R M Batt
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

4.  Small intestinal permeability and serum folate and cobalamin absorption after surgical construction of permanent jejunal fistulas in laboratory beagle dogs.

Authors:  Rafael Frias; Jaana Harmoinen; Outi Laitinen-Vapaavuori; Thomas Spillmann; Satu Sankari; Elias Westermarck
Journal:  Comp Med       Date:  2010-10       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.